top of page

PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION

Product details

Registration number: SIN08899P

Classification: Prescription Only

Active ingredients:

  • COPPER CHLORIDE DIHYDRATE
  • MANGANESE CHLORIDE TETRAHYDRATE
  • POTASSIUM IODIDE
  • SODIUM FLUORIDE
  • SODIUM SELENITE ANHYDROUS
  • ZINC CHLORIDE

Strength:

  • 53.7 mcg/ml
  • 3.6 mcg/ml
  • 1.31 mcg/ml
  • 126 mcg/ml
  • 4.38 mcg/ml
  • 521 mcg/ml

Dosage form: INJECTION

Route: INTRAVENOUS

Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD

ATC code: A12CX

HSA approval date: 4 September 1996

Manufacturer(s): HP HALDEN PHARMA AS

Manufacturing country/countries: NORWAY

What are the HSA registration number and classification for PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN08899P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • COPPER CHLORIDE DIHYDRATE
  • MANGANESE CHLORIDE TETRAHYDRATE
  • POTASSIUM IODIDE
  • SODIUM FLUORIDE
  • SODIUM SELENITE ANHYDROUS
  • ZINC CHLORIDE

Strength:

  • 53.7 mcg/ml
  • 3.6 mcg/ml
  • 1.31 mcg/ml
  • 126 mcg/ml
  • 4.38 mcg/ml
  • 521 mcg/ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION?

According to the HSA dataset updated 7 August 2026:

Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD

Source for this answer

Which manufacturers and countries are listed for PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): HP HALDEN PHARMA AS

Manufacturing country/countries: NORWAY

Source for this answer

Where can I look up PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN08899P or the exact product name PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION. The general register link does not preselect this product.

Source for this answer

What are the source dates for this PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN08899P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page